Results 51 to 60 of about 11,560 (188)

Measurement of Fractional Exhaled Nitric Oxide in Stable Bronchiectasis

open access: yesTuberculosis and Respiratory Diseases, 2013
Fractional exhaled nitric oxide (FeNO) can be measured easily, rapidly, and noninvasively for the assessment of airway inflammation, particularly mediated by eosinophil, such as asthma. In bronchiectasis (BE), the pathogenesis has been known as chronic airway inflammation and infection with abnormal airway dilatation; however, there are little studies ...
Cho, Young-Jae   +5 more
openaire   +2 more sources

Tobacco Smoke Exposure and Fractional Exhaled Nitric Oxide Levels among U.S. Adolescents

open access: yesNitric oxide, 2021
Background: Fractional exhaled nitric oxide (FeNO) can objectively guide clinical practice in the assessment, diagnosis, and treatment of eosinophilic airway inflammation.
A. Merianos   +3 more
semanticscholar   +1 more source

Fractional exhaled nitric oxide in a respiratory healthy general population through the lifespan.

open access: yesPulmonology
INTRODUCTION AND OBJECTIVES The fractional exhaled fraction of nitric oxide (FeNO) is used in clinical practice for asthma diagnosis, phenotyping, and therapeutic management. Therefore, accurate thresholds are crucial.
C. Bal   +8 more
semanticscholar   +1 more source

Clinical utility of fractional exhaled nitric oxide in severe asthma management

open access: yesEuropean Respiratory Journal, 2020
Asthma is a chronic inflammatory disease of the airways, affecting over 350 million people worldwide and placing a significant burden on healthcare providers and wider society.
A. Menzies-Gow, A. Mansur, C. Brightling
semanticscholar   +1 more source

Fractional exhaled nitric oxide in the assessment of exercise‐induced bronchoconstriction: A multicenter retrospective analysis of UK‐based athletes

open access: yesScandinavian Journal of Medicine & Science in Sports, 2022
Exercise‐induced bronchoconstriction (EIB) is not only highly prevalent in people with asthma, but can also occur independently, particularly in athletes.
J. Dickinson   +8 more
semanticscholar   +1 more source

Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review

open access: yesEuropean Clinical Respiratory Journal, 2021
Background: Precision medicine means linking the right patient to the right management strategy including best possible pharmacological therapy, considering the individual variability of the disease characteristics, type of inflammation, genes ...
C. Ulrik, P. Lange, O. Hilberg
semanticscholar   +1 more source

The Association Between Personal Air Pollution Exposures and Fractional Exhaled Nitric Oxide (FeNO): A Systematic Review

open access: yesCurrent Environmental Health Reports
Airway inflammation is a common biological response to many types of environmental exposures and can lead to increased nitric oxide (NO) concentrations in exhaled breath.
Abhay Anand   +2 more
semanticscholar   +1 more source

Fungi composition in settled dust associated with fractional exhaled nitric oxide in school children with asthma.

open access: yesScience of the Total Environment, 2022
Fungi exposure has been significantly linked to respiratory illness. However, numerous fungi taxa that are potentially allergenic still undocumented and leave a barrier to establishing a clear connection between exposure and health risks.
Khairul Nizam Mohd Isa   +5 more
semanticscholar   +1 more source

Safety and pharmacokinetics of inhaled aloxistatin: A first‐in‐human phase 1 dose escalation trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Aloxistatin (E64d) is a membrane‐permeable cysteine protease inhibitor prodrug that is converted by esterases to the active metabolite E64c (loxistatin). This first‐in‐human study evaluated the safety, tolerability and pharmacokinetics of single ascending doses of inhaled E64d in healthy volunteers.
Sebastian Fähndrich   +24 more
wiley   +1 more source

Correlation of fractional exhaled nitric oxide (FeNO) and clinical outcomes in patients with chronic obstructive pulmonary disease: A prospective cohort study.

open access: yesRespiratory Medicine
BACKGROUND Fractional exhaled nitric oxide (FeNO) is an acceptable and noninvasive marker for defining eosinophilic airway inflammation. Further study is necessary to clarify the role of FeNO in patients with chronic obstructive pulmonary disease (COPD).
W. Keeratichananont   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy